AlphaCrest Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$411K Buy
2022
Q2
$387K Buy
2022
Q1
Sell
2021
Q4
$690K Buy
2021
Q3
$575K Sell
2021
Q2
$1.06M Buy
2021
Q1
Sell
2020
Q4
$968K Buy
2020
Q3
$205K Sell
2020
Q2
$256K Buy
2020
Q1
Sell
2019
Q4
$525K Sell
2019
Q3
$1.01M Buy
2019
Q2
$1.01M Buy
2019
Q1
$660K Buy
2018
Q4
$383K Buy